Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Recruiting 2Completed 2

Sponsor Class

OTHER 4

Study Type

Observational 3Interventional 1

Sponsor

Cancer Type

Gynecologic 4Thoracic 2

Conditions

Ovarian Neoplasms 3Uterine Neoplasms 1Kenny-Caffey syndrome, Type 1 1Endometrial Neoplasms 1

Interventions

Paclitaxel 79Cisplatin 72Carboplatin 72Bevacizumab 29Radiotherapy 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 19Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 15liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Taxes 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Injections 7Cytoreduction Surgical Procedures 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Unknown × Poly(ADP-ribose) Polymerase Inhibitors × Gynecologic × Clear all
NCT04724031 2023-03-14

Real World Data Analysis of PARP Inhibitors Use in Patients With Ovarian Cancer

Hellenic Cooperative Oncology Group

Unknown
150 enrolled
Gynecologic

Ovarian Neoplasms

NCT05044091 2021-09-14

HOPEI

Jiangsu Cancer Institute & Hospital

Unknown
100 enrolled
Gynecologic

Kenny-Caffey syndrome, Type 1, Ovarian Neoplasms

NCT03951415 2021-04-01

DOMEC

Leiden University Medical Center

Phase 2 Unknown
55 enrolled
Gynecologic

Uterine Neoplasms, Endometrial Neoplasms

NCT04582552 2021-01-20

ROMP

Jiangsu Cancer Institute & Hospital

Unknown
60 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡